REG - Belluscura PLC - Posting of Circular and Notice of General Meeting

BelluscuraAnnouncement

12/02/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250212:nRSL7597Wa&default-theme=true

RNS Number : 7597W  Belluscura PLC  12 February 2025

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO
THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF
SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION
OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN
OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR
OR OTHERWISE ACQUIRE ANY NEW SHARES OF BELLUSCURA PLC.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF ENGLISH LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"), AND IS
DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF
MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

12 February 2025

 

Belluscura plc

("Belluscura" or the "Company")

 

Posting of Circular and Notice of General Meeting

Belluscura plc (AIM: BELL), a UK medical device company focused on developing
oxygen enrichment technology spanning broad industries and therapies,
announces that further to the announcements made on 6, 7 and 11  February
2025, a circular (the "Circular"), including the Notice of General Meeting,
was posted to shareholders on 11 February 2025 with details of the Fundraising
and putting forward Resolutions to enable completion of the Fundraising.

The General Meeting will be held at the offices of Dowgate Capital Limited, 15
Fetter Lane, London EC4A 1BW at 11.00 a.m. on 28 February 2025

 A copy of the Circular will shortly be available on the Company's website
at www.belluscura.com
(https://protect.checkpoint.com/v2/r06/___http:/www.belluscura.com___.ZXV3MjpuZXh0MTU6YzpvOjIyZTFjNmJkOWU1MjZlM2MzYzI2OTExN2I3ZDVlNjUzOjc6ZmU1MjoxNzBiMGE1ZDQ5OThlNjI0NmU3MDdlNDg1MmY3YzRkYTA4NTIzNzQ1MDM3Y2M5ZTQ4ZDA2NzEzOTBhNTBlYThlOnA6VDpU)
.

In order for eligible Shareholders to be able to qualify for VCT/EIS relief,
the WRAP Retail Offer Shares are expected to be issued and admitted to trading
on AIM on or around 4 March 2025, along with  56,534,389 VCT/EIS Placing
Shares (subject to the passing of the Resolutions) and the remaining
 109,616,986 Conditional Placing Shares are expected to be issued and
admitted to trading on AIM on or around 5 March 2025 (subject to the passing
of the Resolutions).  Accordingly, the WRAP Retail Offer is no longer
conditional on completion of the issue of the 109,616,986 Conditional Placing
Shares, being the final tranche of New Ordinary Shares to be issued pursuant
to the Fundraising.

 EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 Announcement of proposed Fundraise                                              6 February 2025
 Posting of the Circular                                                         11 February 2025
 First Admission and commencement of dealings in the Firm Placing Shares         8.00 a.m. on 11 February 2025
 Crediting of Firm Placing Shares in Uncertificated Form to CREST accounts       11 February 2025
 Latest time and date for receipt of proxy appointments and CREST and Proxymity  11.00 a.m. on 26 February 2025
 voting instructions for the General Meeting
 General Meeting                                                                 11.00 a.m. on 28 February 2025
 Announcement of the result of the General Meeting                               by 4.30 p.m. on 28 February 2025
 Second Admission and commencement of dealings in the VCT/EIS Placing Shares     8.00 a.m. on 4 March 2025
 and the WRAP Retail Offer Shares
 Crediting of VCT/EIS Placing Shares and WRAP Retail Offer Shares in             4 March 2025
 Uncertificated Form to CREST accounts
 Third Admission and commencement of dealings in the Conditional Placing Shares  8.00 a.m. on 5 March 2025
 Crediting of Conditional Placing Shares in Uncertificated Form to CREST         5 March 2025
 accounts
 Posting of share certificates for the New Ordinary Shares by the Registrar      within 14 days of each respective Admission
 (where applicable)

Notes:

1.References to times and dates in this Document are to London times and dates
unless otherwise stated.

2.If any of the above times or dates should change, the revised times and/or
dates will be notified to Shareholders by an announcement on an RIS (and
posted on the Company's website).

3.All events in the above timetable following the General Meeting, in
particular the issue of the New Ordinary Shares by the Company, are
conditional upon approval by the Shareholders of the Resolutions.

4.If any of the details contained in the timetable above should change, the
revised times and dates will be notified to Shareholders by means of an
announcement through a Regulatory Information Service.

Capitalised terms used in this announcement shall, unless otherwise defined,
have the same meanings as set out in the Company's announcement of 7 February
2025 and the Circular.

 

Enquiries:

For further information please contact:

 

 Belluscura plc                                             Tel: +44 (0)20 3128 8100
 Adam Reynolds, Chairman

 Robert Rauker, Chief Executive Officer

 Simon Neicheril, Chief Financial Officer

                                                            Tel: +44 (0)20 3368 3550

 SPARK Advisory Partners Limited

 Nominated Adviser
 Neil Baldwin / Jade Bayat

                                                            Tel: +44 (0)20 3903 7715

 Dowgate Capital Limited

 Joint Broker
 James Serjeant (Corporate Broking)

 Colin Clime (Sales)

 Russell Cook / Daniel Ingram (Corporate Finance)

 Allenby Capital Ltd                                        Tel: +44 (0)20 3328 5656

 Joint Broker
 Guy McDougall / Amrit Nahal (Sales and Corporate Broking)

 Jeremy Porter / Lauren Wright (Corporate Finance)

 MHP                                                        Tel: +44 (0)20 3128 8100

 Financial PR & Investor Relations                          email: Belluscura@mhpgroup.com (about:blank)
 Katie Hunt/Matthew Taylor

 

For further information, please visit https://ir.belluscura.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOGFFFILFTILLIE